CHRISTOPHER DO: Open Payments
NPI 1346765955 · ANAHEIM, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$859 in 30 payments from 16 companies in 2025. Trend: 2023 $1,466 · 2024 $2,570 · 2025 $859
Food & beverage: $859
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $175 |
| Novartis Pharmaceuticals Corporation | 5 | $127 |
| ABBVIE INC. | 5 | $120 |
| Merck Sharp & Dohme LLC | 3 | $79 |
| GlaxoSmithKline, LLC. | 2 | $56 |
| Daiichi Sankyo Inc. | 2 | $48 |
| ADC THERAPEUTICS AMERICA, INC. | 2 | $45 |
| PUMA BIOTECHNOLOGY, INC. | 1 | $29 |
| SOBI, INC | 1 | $28 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
Products named: RYBREVANT, KEYTRUDA, EPKINLY, KISQALI, PLUVICTO, Enhertu, ZYNLONTA, VENCLEXTA.
Industry payments across CA — which companies pay providers there.
